Taipei, Taiwan, 1st December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E fundin.
Taipei, Taiwan, 1st November 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that it has received agreement from the US Food and Drug Administration (FDA) on the Phase 3 clinical trial design for its lead candidate for Dry Eye Disease (DED), BRM421, at the End of Phase 2 M.
Award-winning innovation from Birmingham Biotech LTD and University of Birmingham is now available in the UKCreates a barrier in the nose to trap virusesPowerful anti-viral formula remains in the nose for six hours after applicationBirmingham, UK, 28th October 2022 / Sciad Newswire / Birmingham Biotech LTD, an inno.
London, United Kingdom, 19th October 2022 / Sciad Newswire / Taking place on 17th November in London, Pharma Integrates is the must-attend event for leaders, strategists and innovators across pharma & healthcare looking to revolutionise modern medicine. An opportunity to make connections, discuss how to overcome.
Falmouth, UK, 11th October 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) today announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with oth.